ABC
ALNY icon

Associated Banc-Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History

Associated Banc-Corp’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-33
Closed -$5K – 989
2020
Q2 		$5K Hold
33
– – ﹤0.01% 427
2020
Q1 		$4K Buy
+33
New +$3.81K ﹤0.01% 420

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Associated Banc-Corp's ALNY Position: Q3 2020 in Review

Associated Banc-Corp sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2020, closing a stake of 33 shares — an estimated $5K sold.

Associated Banc-Corp first reported a position in ALNY in Q1 2020 and held it in 2 quarters. The position peaked at $5K in Q2 2020. 356 funds tracked by Wall St. Rank hold ALNY as of Q3 2020.

  • Associated Banc-Corp reported no remaining Alnylam Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Associated Banc-Corp sold 33 Alnylam Pharmaceuticals shares in Q3 2020, an estimated $5K.
  • Associated Banc-Corp first reported a position in Alnylam Pharmaceuticals in Q1 2020 and held it in 2 quarters.
  • Associated Banc-Corp's Alnylam Pharmaceuticals position peaked at $5K in Q2 2020.
  • 356 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2020.

Based on Associated Banc-Corp's 13F filing for Q3 2020, filed 12 Nov 2020.